Previous studies have demonstrated that AML cells expressing FLT3‐internal tandem duplication (ITD) are more sensitive to the proteasome inhibitor bortezomib (Bz) than FLT3 wild‐type cells, with this cytotoxicity being mediated by autophagy (Atg). The gene discussed is FLT3; the disease is acute myeloid leukemia.